[1]
“USING BAYESIAN METHODS IN THE TASK OF MODELING THE PATIENTS’ PHARMACORESISTANCE DEVELOPMENT”, IAPGOS, vol. 12, no. 2, pp. 77–82, Jun. 2022, doi: 10.35784/iapgos.2968.